PT - JOURNAL ARTICLE AU - Marek Kochańczyk AU - Frederic Grabowski AU - Tomasz Lipniacki TI - Dynamics of COVID-19 pandemic at constant and time-dependent contact rates AID - 10.1101/2020.03.13.20035485 DP - 2020 Jan 01 TA - medRxiv PG - 2020.03.13.20035485 4099 - http://medrxiv.org/content/early/2020/03/29/2020.03.13.20035485.short 4100 - http://medrxiv.org/content/early/2020/03/29/2020.03.13.20035485.full AB - We constructed a simple Susceptible–Infected–Infectious–Excluded model of the spread of COVID-19. The model is parametrised only by the average incubation period, τ, and two rate parameters: contact rate, rC, and exclusion rate, rE. The rates can be manipulated by non-therapeutic interventions and determine the basic reproduction number, R = rC/rE, and, together with τ, the daily multiplication coefficient at the early exponential phase, β. Initial β determines the reduction of rC required to contain epidemic spread. In the long-term, we consider a scenario based on typical social behaviours, in which rC first decreases in response to a surge of daily new cases, forcing people to self-isolate, and then slowly increases when people gradually accept higher risk. Consequently, initial abrupt epidemic spread is followed by a plateau and slow regression. This scenario, although economically and socially devastating, will grant time to develop, produce, and distribute a vaccine, or at least limit daily cases to a manageable number.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the National Science Centre (Poland) grant 2018/29/B/NZ2/00668Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData referred in the manuscript are available at JHU CSSE, https://systems.jhu.edu/research/public-health/ncov, accessed: 2020-03-20 and https://ourworldindata.org/covid-testing, accessed: 2020-03-20 http://pmbm.ippt.pan.pl/model/covid19